tradingkey.logo
搜尋

Teva Pharmaceutical Industries Ltd

TEVA
添加自選
33.210USD
+1.010+3.14%
收盤 06/23, 16:00美東報價延遲15分鐘
38.24B總市值
26.97本益比TTM

Teva Pharmaceutical Industries Ltd

33.210
+1.010+3.14%

關於 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltd簡介

公司代碼TEVA
公司名稱Teva Pharmaceutical Industries Ltd
上市日期Feb 06, 2087
CEOFrancis (Richard D)
員工數量33892
證券類型Depository Receipt
年結日Feb 06
公司地址124 Dvora Hanevi'a St.
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Israel
郵編6944020
電話97239148213
網址https://www.tevapharm.com/
公司代碼TEVA
上市日期Feb 06, 2087
CEOFrancis (Richard D)

Teva Pharmaceutical Industries Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

常見問題

Teva Pharmaceutical Industries Ltd的前五大股東是誰?

Teva Pharmaceutical Industries Ltd的前五大股東如下:Prof. Varda Shalev

有多少機構持有Teva Pharmaceutical Industries Ltd(TEVA)的股份?

截至2026Q1,共有1226家機構持有Teva Pharmaceutical Industries Ltd的股份,合計持有的股份價值約為725.07M,占公司總股份的62.27% 。與2025Q4相比,機構持股有所增加,增幅為9191465.00。

哪個業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大?

在2026Q1,Generic products業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大,創收9.42B,占總收入的54.59% 。
KeyAI